SPY389.63+0.17 0.04%
DIA312.42-0.01 0.00%
IXIC11,354.62-33.88 -0.30%

Hutchmed Says FDA Requires Additional Trial for Approval of Advanced Tumor Drug; Shares Fall

MT Newswires · 05/02/2022 03:35

Please log in to view news